Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based combination therapy and gene therapy are new strategies to potentially overcome the limitations of TRAIL, however, the lack of efficient and low toxic vectors remains the major obstacle. In this study, we developed a hyaluronic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shengpeng, Shao, Min, Zhong, Zhangfeng, Wang, Anqi, Cao, Jiliang, Lu, Yucong, Wang, Yitao, Zhang, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240989/
https://www.ncbi.nlm.nih.gov/pubmed/29172759
http://dx.doi.org/10.1080/10717544.2017.1406558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240989/
https://www.ncbi.nlm.nih.gov/pubmed/29172759
http://dx.doi.org/10.1080/10717544.2017.1406558

Ejemplares similares